Last month’s performance of -20.77% for Caribou Biosciences Inc (CRBU) is certainly impressive

Caribou Biosciences Inc (NASDAQ: CRBU) kicked off on Monday, down -8.48% from the previous trading day, before settling in for the closing price of $0.87. Over the past 52 weeks, CRBU has traded in a range of $0.66-$4.39.

Annual sales at Healthcare sector company grew by 42.68% over the past five years. While this was happening, its average annual earnings per share was recorded -6.20%. With a float of $80.81 million, this company’s outstanding shares have now reached $92.38 million.

Let’s look at the performance matrix of the company that is accounted for 147 employees. In terms of profitability, gross margin is 84.33%, operating margin of -1667.16%, and the pretax margin is -1492.04%.

Caribou Biosciences Inc (CRBU) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Caribou Biosciences Inc is 13.11%, while institutional ownership is 59.58%. The most recent insider transaction that took place on Mar 14 ’25, was worth 20,400. In this transaction President and CEO of this company bought 20,000 shares at a rate of $1.02, taking the stock ownership to the 3,369,395 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Legal Officer sold 3,564 for $1.35, making the entire transaction worth $4,811. This insider now owns 443,502 shares in total.

Caribou Biosciences Inc (CRBU) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -6.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.17% during the next five years compared to -33.41% drop over the previous five years of trading.

Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators

Take a look at Caribou Biosciences Inc’s (CRBU) current performance indicators. Last quarter, stock had a quick ratio of 7.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.45.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.65, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.72 in one year’s time.

Technical Analysis of Caribou Biosciences Inc (CRBU)

Caribou Biosciences Inc (NASDAQ: CRBU) saw its 5-day average volume 0.99 million, a negative change from its year-to-date volume of 1.22 million. As of the previous 9 days, the stock’s Stochastic %D was 57.73%. Additionally, its Average True Range was 0.10.

During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 7.56%, which indicates a significant decrease from 40.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.82% in the past 14 days, which was higher than the 71.95% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.0983, while its 200-day Moving Average is $1.7462. Nevertheless, the first resistance level for the watch stands at $0.8801 in the near term. At $0.9599, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.0000. If the price goes on to break the first support level at $0.7602, it is likely to go to the next support level at $0.7201. The third support level lies at $0.6403 if the price breaches the second support level.

Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats

The company with the Market Capitalisation of 74.42 million has total of 93,005K Shares Outstanding. Its annual sales at the moment are 9,990 K in contrast with the sum of -149,110 K annual income. Company’s last quarter sales were recorded 2,080 K and last quarter income was -35,490 K.